66 related articles for article (PubMed ID: 22863759)
21. Inhibitor of growth protein 4 interacts with Beclin 1 and represses autophagy.
Sica V; Bravo-San Pedro JM; Chen G; Mariño G; Lachkar S; Izzo V; Maiuri MC; Niso-Santano M; Kroemer G
Oncotarget; 2017 Oct; 8(52):89527-89538. PubMed ID: 29163768
[TBL] [Abstract][Full Text] [Related]
22. Expression of ING4 is negatively correlated with cellular proliferation and microvessel density in human glioma.
Shao B; Liu E
Oncol Lett; 2017 Sep; 14(3):3663-3668. PubMed ID: 28927128
[TBL] [Abstract][Full Text] [Related]
23. Defining the minimal peptide sequence of the ING1b tumour suppressor capable of efficiently inducing apoptosis.
Boyko A; Riabowol K
Cell Death Discov; 2015; 1():15048. PubMed ID: 27551477
[TBL] [Abstract][Full Text] [Related]
24. INGs are potential drug targets for cancer.
Zhang R; Jin J; Shi J; Hou Y
J Cancer Res Clin Oncol; 2017 Feb; 143(2):189-197. PubMed ID: 27544390
[TBL] [Abstract][Full Text] [Related]
25. Inhibitor of growth-4 is a potential target for cancer therapy.
Yuan S; Jin J; Shi J; Hou Y
Tumour Biol; 2016 Apr; 37(4):4275-9. PubMed ID: 26803518
[TBL] [Abstract][Full Text] [Related]
26. Functional genomics screening utilizing mutant mouse embryonic stem cells identifies novel radiation-response genes.
Loesch K; Galaviz S; Hamoui Z; Clanton R; Akabani G; Deveau M; DeJesus M; Ioerger T; Sacchettini JC; Wallis D
PLoS One; 2015; 10(4):e0120534. PubMed ID: 25853515
[TBL] [Abstract][Full Text] [Related]
27. Gemcitabine sensitizes lung cancer cells to Fas/FasL system-mediated killing.
Siena L; Pace E; Ferraro M; Di Sano C; Melis M; Profita M; Spatafora M; Gjomarkaj M
Immunology; 2014 Feb; 141(2):242-55. PubMed ID: 24128051
[TBL] [Abstract][Full Text] [Related]
28. Tumor suppressor ING4 overexpression contributes to proliferation and invasion inhibition in gastric carcinoma by suppressing the NF-κB signaling pathway.
Li S; Fan T; Liu H; Chen J; Qin C; Ren X
Mol Biol Rep; 2013 Oct; 40(10):5723-32. PubMed ID: 24057236
[TBL] [Abstract][Full Text] [Related]
29. Lung cancer cells that survive ionizing radiation show increased integrin α2β1- and EGFR-dependent invasiveness.
Li X; Ishihara S; Yasuda M; Nishioka T; Mizutani T; Ishikawa M; Kawabata K; Shirato H; Haga H
PLoS One; 2013; 8(8):e70905. PubMed ID: 23951036
[TBL] [Abstract][Full Text] [Related]
30. p53 tumor suppressor gene therapy for cancer.
Roth JA; Swisher SG; Meyn RE
Oncology (Williston Park); 1999 Oct; 13(10 Suppl 5):148-54. PubMed ID: 10550840
[TBL] [Abstract][Full Text] [Related]
31. Involvement of FHIT in lung carcinogenesis prospects for future clinical gene therapy applications.
Sozzi G; Andriani F; Gramegna M; Roz L
Suppl Tumori; 2002; 1(4):S62. PubMed ID: 12415825
[No Abstract] [Full Text] [Related]
32. Enhanced radiosensitivity of non-small-cell lung cancer (NSCLC) by adenovirus-mediated ING4 gene therapy.
Ling C; Xie Y; Zhao D; Zhu Y; Xiang J; Yang J
Cancer Gene Ther; 2012 Oct; 19(10):697-706. PubMed ID: 22863759
[TBL] [Abstract][Full Text] [Related]
33. Synergistic tumor suppression by adenovirus-mediated inhibitor of growth 4 and interleukin-24 gene cotransfer in hepatocarcinoma cells.
Xie Y; Lv H; Sheng W; Miao J; Xiang J; Yang J
Cancer Biother Radiopharm; 2011 Dec; 26(6):681-95. PubMed ID: 21988227
[TBL] [Abstract][Full Text] [Related]
34. Enhanced tumor suppression by an ING4/IL-24 bicistronic adenovirus-mediated gene cotransfer in human non-small cell lung cancer cells.
Zhu Y; Lv H; Xie Y; Sheng W; Xiang J; Yang J
Cancer Gene Ther; 2011 Sep; 18(9):627-36. PubMed ID: 21660060
[TBL] [Abstract][Full Text] [Related]
35. Synergistic tumor suppression by adenovirus-mediated ING4/PTEN double gene therapy for gastric cancer.
Zhang H; Zhou X; Xu C; Yang J; Xiang J; Tao M; Xie Y
Cancer Gene Ther; 2016 Jan; 23(1):13-23. PubMed ID: 26564429
[TBL] [Abstract][Full Text] [Related]
36. Adenovirus-mediated ING4/IL-24 double tumor suppressor gene co-transfer enhances antitumor activity in human breast cancer cells.
Zhao Y; Li Z; Sheng W; Miao J; Yang J
Oncol Rep; 2012 Oct; 28(4):1315-24. PubMed ID: 22842937
[TBL] [Abstract][Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
